六君子汤对宫颈癌辅助放化疗不良反应的影响

来源 :新中医 | 被引量 : 0次 | 上传用户:zf524979
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:观察六君子汤对宫颈鳞癌辅助放化疗期间不良反应的影响。方法:将120例患者随机分为2组各60例,对照组单纯予同步放化疗治疗;观察组在同步放化疗期间口服六君子汤治疗,放化疗结束评估疗效。结果:2组生存质量提高情况比较,差异有显著性意义(P<0.05)。放化疗过程中,2组恶心呕吐发生率比较,差异有显著性意义(P<0.05);2组腹泻、血清转氨酶升高、胆红素升高、口腔炎的发生率分别比较,差异均无显著意意义(P>0.05);2组中性粒细胞减少、血红蛋白减少发生率分别比较,差异均有显著性意义(P<0.05);2组血小板减少发生率比较,差异无显著性意义(P>0.05)。结论:口服六君子汤可增强患者对放化疗的耐受力,有利于放化疗的顺利进行,起到增效减毒的作用。 Objective: To observe the effect of Liujunzi Decoction on adverse reactions during adjuvant chemotherapy and radiotherapy for cervical squamous cell carcinoma. Methods: 120 patients were randomly divided into two groups of 60 cases, the control group was treated with concurrent radiotherapy and chemotherapy alone. The observation group was treated with Liujunzitang during concurrent chemoradiotherapy, and the curative effect was evaluated at the end of radiotherapy and chemotherapy. Results: There was significant difference between the two groups in quality of life improvement (P <0.05). During radiotherapy and chemotherapy, the incidence of nausea and vomiting in the two groups was significantly different (P <0.05). There was no difference between the two groups in the incidence of diarrhea, elevated serum transaminase, elevated bilirubin and stomatitis (P> 0.05). There was significant difference in the incidence of neutropenia and hemoglobin decrease between the two groups (P <0.05). There was no significant difference in the incidence of thrombocytopenia between the two groups P> 0.05). Conclusion: Oral Liujunzi decoction can enhance the tolerance of patients to radiotherapy and chemotherapy, is conducive to the smooth progress of radiotherapy and chemotherapy, play a synergistic effect attenuated.
其他文献
崇明县由崇明、长兴、横沙三岛组成,三岛陆域总面积1411km~2。崇明岛三面环江,一面临海,西接滚滚长江,东濒浩瀚东海,南与浦东新区、宝山区及江苏省太仓市隔水相望,北与江苏省
会议
会议
鸡西矿业集团公司张辰煤矿西三采区3
期刊
目的利用钼钯摄影(MG)、超声(US)、复合成像(CI)、实时弹性成像(RTE)估算肿瘤大小,并与组织病理标本的大小进行比较。方法测量97个恶性乳腺病灶的最大径,US和CI测2次,US1/CI1
会议
会议
会议
会议
会议